Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Go back to Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 13.69 +0.19 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.50 | 52 Week High | $5.58 | |||
| Open | $13.70 | 52 Week Low | $3.60 | |||
| Day High | $13.75 | P/E | N/A | |||
| Day Low | $13.65 | EPS | $0.00 | |||
| Volume | 3,631,475 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 41.60 -0.78 (1.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.38 | 52 Week High | $44.76 | |||
| Open | $40.91 | 52 Week Low | $36.81 | |||
| Day High | $41.67 | P/E | N/A | |||
| Day Low | $40.89 | EPS | $0.00 | |||
| Volume | 3,854,483 | |||||
